National Institute on Deafness and Other Communication Disorders; Amended Notice of Meeting, 52978-52979 [2022-18705]

Download as PDF 52978 Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel—Team-Based Design (R25) Review. Date: October 26, 2022. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Suite 957, Bethesda, MD 20892, (301) 496–4773, zhour@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.) Dated: August 19, 2022. Victoria E. Townsend Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18700 Filed 8–29–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES khammond on DSKJM1Z7X2PROD with NOTICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. VerDate Sep<11>2014 17:24 Aug 29, 2022 Jkt 256001 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed). Date: September 29–30, 2022. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F21B, Rockville, MD 20892 (Virtual Meeting). Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F21B, Rockville, MD 20852, 240–669–5026, haririmf@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 24, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18650 Filed 8–29–22; 8:45 am] personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Pediatrics Study Section. Date: October 20, 2022. Closed: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Room 2137B, 6710B Rockledge Drive, Bethesda, MD 20892 (Video Assisted Meeting). Contact Person: Joanna Kubler-Kielb, Ph.D., Scientific Review Officer, Scientific Review Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, 301–435–6916, kielbj@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/org/der/srb, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program No. 93.865, Research for Mothers and Children, National Institutes of Health.) Dated: August 24, 2022. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18648 Filed 8–29–22; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting of the Pediatrics Study Section. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute on Deafness and Other Communication Disorders; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Deafness and Other Communication Disorders Advisory Council, September 08, 2022, 10:00 a.m. to September 09, 2022, 01:00 p.m., PORTER NEUROSCIENCE RESEARCH CENTER, Building 35A, 35 Convent Drive, Bethesda, MD, 20892 which was published in the Federal Register on July 13, 2022, 87 FR 41732. This notice is being amended to change the meeting location from Building 35 to a virtual meeting. The URL link to the meeting is https:// videocast.nih.gov/watch=45775 (9/8) E:\FR\FM\30AUN1.SGM 30AUN1 52979 Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices within 60 days of the date of this publication. and https://videocast.nih.gov/ watch=45777 (9/9). The meeting is partially Closed to the public. [FR Doc. 2022–18705 Filed 8–29–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request; Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research (Office of the Director) AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the Office of Clinical Research (OCR), Office of the Director (OD), National Institutes of Health, will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. DATES: Comments regarding this information collection are best assured of having their full effect if received SUMMARY: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Dr. Anne Zajicek, M.D., Pharm.D., Deputy Director, Office of Clinical Research, NIH Office of the Director, Building 1, Room 208A, MSC– 0155, Bethesda, Maryland, 20892 or call non-toll-free number (301) 480–9913 or Email your request, including your address to: zajiceka@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimizes the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, FOR FURTHER INFORMATION CONTACT: Dated: August 25, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. mechanical, or other technological collection techniques or other forms of information technology. Proposed Collection Title: Application and Impact of Clinical Research Training on Healthcare Professionals in Academia and Clinical Research, 0925–0764, exp., date 11/30/ 2022, Office of Clinical Research (OCR), National Institutes of Health (NIH), Office of the Director (OD). Need and Use of Information Collection: The purpose of this survey is to assess the long-term impact and outcomes of clinical research training programs provided by the OCR located in the NIH OD over a ten-year followup period. The information received from respondents will provide insight on the following: impact of the courses on (a) promotion of professional competence, (b) research productivity and independence, and (c) future career development within clinical, translational and academic research settings. These surveys will provide preliminary data and guidance in (1) developing recommendations for collecting outcomes to assess the effectiveness of the training courses, and (2) tracking the impact of the curriculum on participants’ ability to perform successfully in academic, nonacademic, research, and non-research settings. OMB approval is requested for three years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 3,674. ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average time per response (in hours) Total annual burden hours Type of respondents OCR Learning Portal Registration ......................................... Healthcare Professionals .............. Students ........................................ General Public .............................. Healthcare Professionals .............. Students ........................................ General Public .............................. Healthcare Professionals .............. Students ........................................ General Public .............................. Healthcare Professionals .............. Students ........................................ General Public .............................. Healthcare Professionals .............. Students ........................................ General Public .............................. Healthcare Professionals .............. 2,000 3,000 1,000 1,000 2,000 1,000 1,000 2,000 1,000 1,000 2,000 1,000 1,000 2,000 1,000 20 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 10/60 333 500 167 167 333 167 167 333 167 167 333 167 167 333 167 3 Healthcare Professionals .............. 20 1 10/60 3 Total ....................................... 22,040 22,040 ........................ 3,674 Introduction to the Principles and Practice of Clinical Research (IPPCR) Lecture Evaluation. IPPCR Final Course Evaluation ............................................ Principles of Clinical Pharmacology (PCP) Lecture Evaluation. PCP Final Course Evaluation ................................................ khammond on DSKJM1Z7X2PROD with NOTICES Estimated number of respondents Form name NIH Summer Course in Clinical and Translational Research Course Evaluation. Sabbatical in Clinical Research Management Course Evaluation. VerDate Sep<11>2014 17:24 Aug 29, 2022 Jkt 256001 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 E:\FR\FM\30AUN1.SGM 30AUN1

Agencies

[Federal Register Volume 87, Number 167 (Tuesday, August 30, 2022)]
[Notices]
[Pages 52978-52979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18705]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Deafness and Other Communication Disorders; 
Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Deafness and Other Communication Disorders Advisory Council, September 
08, 2022, 10:00 a.m. to September 09, 2022, 01:00 p.m., PORTER 
NEUROSCIENCE RESEARCH CENTER, Building 35A, 35 Convent Drive, Bethesda, 
MD, 20892 which was published in the Federal Register on July 13, 2022, 
87 FR 41732.
    This notice is being amended to change the meeting location from 
Building 35 to a virtual meeting. The URL link to the meeting is 
https://videocast.nih.gov/watch=45775 (9/8)

[[Page 52979]]

and https://videocast.nih.gov/watch=45777 (9/9). The meeting is 
partially Closed to the public.

    Dated: August 25, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-18705 Filed 8-29-22; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.